102 related articles for article (PubMed ID: 30644602)
1. Cancer stem cells and fibroblast niche cross talk in an in-vitro oral dysplasia model.
Kulsum S; Raju N; Raghavan N; Ramanjanappa RDR; Sharma A; Mehta A; Kuriakose MA; Suresh A
Mol Carcinog; 2019 May; 58(5):820-831. PubMed ID: 30644602
[TBL] [Abstract][Full Text] [Related]
2. Organotypic culture of normal, dysplastic and squamous cell carcinoma-derived oral cell lines reveals loss of spatial regulation of CD44 and p75 NTR in malignancy.
Dalley AJ; AbdulMajeed AA; Upton Z; Farah CS
J Oral Pathol Med; 2013 Jan; 42(1):37-46. PubMed ID: 22643025
[TBL] [Abstract][Full Text] [Related]
3. Curcumin and metformin-mediated chemoprevention of oral cancer is associated with inhibition of cancer stem cells.
Siddappa G; Kulsum S; Ravindra DR; Kumar VV; Raju N; Raghavan N; Sudheendra HV; Sharma A; Sunny SP; Jacob T; Kuruvilla BT; Benny M; Antony B; Seshadri M; Lakshminarayan P; Hicks W; Suresh A; Kuriakose MA
Mol Carcinog; 2017 Nov; 56(11):2446-2460. PubMed ID: 28618017
[TBL] [Abstract][Full Text] [Related]
4. Oral-specific ablation of Klf4 disrupts epithelial terminal differentiation and increases premalignant lesions and carcinomas upon chemical carcinogenesis.
Paparella ML; Abrigo M; Bal de Kier Joffe E; Raimondi AR
J Oral Pathol Med; 2015 Nov; 44(10):801-9. PubMed ID: 25605610
[TBL] [Abstract][Full Text] [Related]
5. Cancer stem cell and its niche in malignant progression of oral potentially malignant disorders.
Surendran S; Siddappa G; Mohan A; Hicks W; Jayaprakash V; Mimikos C; Mahri M; Almarzouki F; Morrell K; Ravi R; Govindan S; Sushma CN; Raghavan N; Birur P; Ilayaraja J; Merzianu M; Reid M; Suresh A; Kuriakose MA
Oral Oncol; 2017 Dec; 75():140-147. PubMed ID: 29224811
[TBL] [Abstract][Full Text] [Related]
6. Growth-regulated oncogene-α from oral submucous fibrosis fibroblasts promotes malignant transformation of oral precancerous cells.
Ye MY; Chen MY; Chang YH; Huang JS; Huang TT; Wong TY; Hong TM; Chen YL
J Oral Pathol Med; 2018 Oct; 47(9):880-886. PubMed ID: 30035347
[TBL] [Abstract][Full Text] [Related]
7. [Alteration of CD44v3 and CD44v6 expression in oral premalignant epithelia].
Gao Y; Liu J; Pang S
Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Sep; 34(5):286-8. PubMed ID: 11776894
[TBL] [Abstract][Full Text] [Related]
8. Patterns of p53 and Ki-67 protein expression in epithelial dysplasia from the floor of the mouth.
Kushner J; Bradley G; Jordan RC
J Pathol; 1997 Dec; 183(4):418-23. PubMed ID: 9496258
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of myofibroblasts in oral epithelial dysplasia and squamous cell carcinoma.
Etemad-Moghadam S; Khalili M; Tirgary F; Alaeddini M
J Oral Pathol Med; 2009 Sep; 38(8):639-43. PubMed ID: 19473444
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition.
Kulsum S; Sudheendra HV; Pandian R; Ravindra DR; Siddappa G; R N; Chevour P; Ramachandran B; Sagar M; Jayaprakash A; Mehta A; Kekatpure V; Hedne N; Kuriakose MA; Suresh A
Mol Carcinog; 2017 Feb; 56(2):694-711. PubMed ID: 27380877
[TBL] [Abstract][Full Text] [Related]
11. The changes of cytokeratin 19 during oral carcinogenesis.
Nie M; Zhong L; Zeng G; Li B
Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 May; 37(3):187-90. PubMed ID: 12419140
[TBL] [Abstract][Full Text] [Related]
12. [Changes of simple epithelial cytokeratin during oral carcinogenesis].
Nie M; Li B; Zeng G; He Z; Chen Q; Zhou M; Luo G; Zeng X
Hua Xi Kou Qiang Yi Xue Za Zhi; 1999 Aug; 17(3):208-9, 220. PubMed ID: 12539284
[TBL] [Abstract][Full Text] [Related]
13. A novel immunocompetent murine model for Candida albicans-promoted oral epithelial dysplasia.
Dwivedi PP; Mallya S; Dongari-Bagtzoglou A
Med Mycol; 2009 Mar; 47(2):157-67. PubMed ID: 18608888
[TBL] [Abstract][Full Text] [Related]
14. Areca nut-induced buccal mucosa fibroblast contraction and its signaling: a potential role in oral submucous fibrosis--a precancer condition.
Chang MC; Lin LD; Wu HL; Ho YS; Hsien HC; Wang TM; Jeng PY; Cheng RH; Hahn LJ; Jeng JH
Carcinogenesis; 2013 May; 34(5):1096-104. PubMed ID: 23349021
[TBL] [Abstract][Full Text] [Related]
15. Differential immunohistochemical expression profiles of perlecan-binding growth factors in epithelial dysplasia, carcinoma in situ, and squamous cell carcinoma of the oral mucosa.
Hasegawa M; Cheng J; Maruyama S; Yamazaki M; Abé T; Babkair H; Saito C; Saku T
Pathol Res Pract; 2016 May; 212(5):426-36. PubMed ID: 26965914
[TBL] [Abstract][Full Text] [Related]
16. PM2.5 induces EMT and promotes CSC properties by activating Notch pathway in vivo and vitro.
Wang Y; Zhong Y; Hou T; Liao J; Zhang C; Sun C; Wang G
Ecotoxicol Environ Saf; 2019 Aug; 178():159-167. PubMed ID: 31002970
[TBL] [Abstract][Full Text] [Related]
17. Putative cancer stem cell marker expression in oral epithelial dysplasia and squamous cell carcinoma.
Abdulmajeed AA; Dalley AJ; Farah CS
J Oral Pathol Med; 2013 Nov; 42(10):755-60. PubMed ID: 23614644
[TBL] [Abstract][Full Text] [Related]
18. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
19. DOK, a cell line established from human dysplastic oral mucosa, shows a partially transformed non-malignant phenotype.
Chang SE; Foster S; Betts D; Marnock WE
Int J Cancer; 1992 Dec; 52(6):896-902. PubMed ID: 1459732
[TBL] [Abstract][Full Text] [Related]
20. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
Sun L; Feng J; Ma L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
